companydata.dkcompanydata.dk

Rangers Pharmaceutical A/S: Financial statements 2025

CVR: 40381015

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092. The solvency ratio was 34.4%.

Gross Profit
DKK -265,330
Profit/Loss
DKK -265,257
Equity
DKK 101,092
Total Assets
DKK 293,534
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--265K-265K101K0
2024--90K1.6M-50.8M-
2023--232K1.2M-52.4M-
2022--1.1M-53.1M-53.6M-
2021--2.7M-2.7M-533K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Rangers Pharmaceutical A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Clifford Starke leaves the board of Rangers Pharmaceutical A/SNov 25, 2025

As of November 25, 2025, Clifford Starke has left the board of directors of Rangers Pharmaceutical A/S.

Niels Løber joins Rangers Pharmaceutical A/S as liquidatorNov 25, 2025

As of November 25, 2025, Niels Løber is registered as liquidator of Rangers Pharmaceutical A/S.

Clifford Starke steps down as adm. dir. of Rangers Pharmaceutical A/SNov 25, 2025

As of November 25, 2025, Clifford Starke has stepped down as adm. dir. of Rangers Pharmaceutical A/S.

Rangers Pharmaceutical A/S enters liquidationNov 25, 2025

On November 25, 2025, Rangers Pharmaceutical A/S entered liquidation.

Dany Vaiman leaves the board of Rangers Pharmaceutical A/SSep 26, 2025

As of September 26, 2025, Dany Vaiman has left the board of directors of Rangers Pharmaceutical A/S.

Michael James Rank leaves the board of Rangers Pharmaceutical A/SSep 26, 2025

As of September 26, 2025, Michael James Rank has left the board of directors of Rangers Pharmaceutical A/S.

Rangers Pharmaceutical A/S: The 2024 annual report is outJul 8, 2025

Rangers Pharmaceutical A/S has published its annual report for 2024. Gross profit came to DKK -90,401, and the net result was DKK 1,641,287.

About Rangers Pharmaceutical A/S

Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.

Source: annual report 2025, Danish Business Authority

Other financial years